Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Harrington

Showing results (151-160 of 197) with videos related to

Pageof 20
Sort By:
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Nature Metabolism|April 27, 2026
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasionTimothy Budden, Noah Palombo, Shilpa Gurung, et al.
Expert Opinion on Biological Therapy|February 19, 2020
Combination therapy with oncolytic viruses and immune checkpoint inhibitorsMatthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, et al.
Gut|December 1, 2016
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancerAdel Samson, Matthew J Bentham, Karen Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Radiation Oncology (London, England)|May 15, 2015
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT studyLiam Welsh, Rafal Panek, Dualta McQuaid, et al.
The Lancet. Oncology|May 3, 2025
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancerMarco Ferrari, Francesca Mularoni, Davide Smussi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanomaEvanthia Galanis, Svetomir N Markovic, Vera J Suman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
Science Translational Medicine|April 13, 2022
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in miceLaura Evgin, Tim Kottke, Jason Tonne, et al.
Pageof 20

Showing results (151-160 of 197) with videos related to

Sort By:
Pageof 20
Cardio-Oncology (London, England)|November 24, 2022
The spectrum of cardiovascular complications related to immune-checkpoint inhibitor treatment : Including myocarditis and the new entity of non inflammatory left ventricular dysfunctionMaria Sol Andres, Sivatharshini Ramalingam, Stuart D Rosen, et al.
Nature Metabolism|April 27, 2026
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasionTimothy Budden, Noah Palombo, Shilpa Gurung, et al.
Expert Opinion on Biological Therapy|February 19, 2020
Combination therapy with oncolytic viruses and immune checkpoint inhibitorsMatthew Chiu, Edward John Lloyd Armstrong, Vicki Jennings, et al.
Gut|December 1, 2016
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancerAdel Samson, Matthew J Bentham, Karen Scott, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2020
Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancerVasileios Angelis, Zayd Tippu, Kroopa Joshi, et al.
Radiation Oncology (London, England)|May 15, 2015
Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT studyLiam Welsh, Rafal Panek, Dualta McQuaid, et al.
The Lancet. Oncology|May 3, 2025
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancerMarco Ferrari, Francesca Mularoni, Davide Smussi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanomaEvanthia Galanis, Svetomir N Markovic, Vera J Suman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2014
A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancerGraham S Taylor, Hui Jia, Kevin Harrington, et al.
Science Translational Medicine|April 13, 2022
Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in miceLaura Evgin, Tim Kottke, Jason Tonne, et al.
Pageof 20